Prostate Cancer Study of Patient Experiences

NCT07096596 | Not Yet Recruiting

• 1 other identifier: ANKARA-UNIVERSITY-YURUN-001
• Study Type: observational
• Target: 3,000
• Locations: 1 country
• Sites: 1

Brief Summary

The PROSPEX (PROstate cancer Study of Patient EXperiences) survey is designed to systematically assess the lived experiences, challenges, and unmet needs of individuals diagnosed with prostate cancer. This observational study will collect patient-reported data on psychological, social, and practical aspects of living with prostate cancer, including the impact on quality of life and access to care. The findings aim to inform the development of patient-centered interventions and improve supportive care strategies in future clinical trials and routine practice.

Conditions

Prostate Cancer

Keywords

prostate cancer; survey; patient experience; oncology; health disparities; patient-reported outcomes; cancer care

Outcome Measures

Primary Outcomes (1)

• Characterization of global disparities in patient-reported experiences and quality of life among individuals with prostate cancer

  Comparative analyses will be performed using survey data to identify and quantify differences in patient experiences, quality of life, and unmet needs across various regions and healthcare settings. Results will be reported as percentages of respondents, with thorough evaluation of territorial, institutional, and socioeconomic differences. Participants will be categorized according to the World Bank's income classification: low- and lower-middle-income countries, upper-middle-income countries, and high-income countries. Descriptive statistics will be used to compare demographic and clinical characteristics, as well as patient-reported outcomes. For categorical data, Pearson Chi-Square or Fisher's Exact test will be applied; for continuous variables, ANOVA will be used. A p-value of less than 0.05 will be considered statistically significant.

  One month

Secondary Outcomes (2)

• Identification of factors associated with reduced quality of life and increased psychosocial burden in prostate cancer patients

  one month

• Assessment of disparities in access to supportive care and information among prostate cancer patients

  one month

Study Arms (1)

Prostate Cancer Patients

Individuals diagnosed with prostate cancer, regardless of disease stage or treatment status. This group includes patients from diverse backgrounds and healthcare settings who are willing to share their experiences, challenges, and needs related to living with prostate cancer.

Other: No Intervention: Observational Cohort

Interventions

No Intervention: Observational Cohort OTHER

No Intervention: Observational Cohort

Prostate Cancer Patients

Eligibility Criteria

• Age: 18 Years+
• Sex: male
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Probability Sample

Study Population

The study population will consist of adult individuals (aged 18 and above) who have been diagnosed with prostate cancer, regardless of disease stage or treatment status. Participants will be recruited internationally and will represent a diverse range of backgrounds, healthcare settings, and geographic regions. The study aims to include patients with varying experiences, including those currently undergoing treatment, those in remission, and those living with advanced or recurrent disease. All participants must be able to provide informed consent and complete the online survey.

You may qualify if:

• Adults (aged 18 years or older). Diagnosed with prostate cancer at any stage (localized, locally advanced, metastatic, or recurrent).
• Able to understand and provide informed consent for participation. Willing and able to complete the online survey in the available languages. Access to the internet and a device to complete the survey.

You may not qualify if:

• Individuals who have not been diagnosed with prostate cancer. Individuals under 18 years of age. Inability to provide informed consent. Inability to complete the survey due to cognitive, language, or technical barriers.

Sponsors & Collaborators

• Ankara University: lead

Study Sites (1)

Ankara University Faculty of Medicine

Ankara, Ankara, 06590, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Prostatic Neoplasms; Neoplasms

Condition Hierarchy (Ancestors)

Genital Neoplasms, Male; Urogenital Neoplasms; Neoplasms by Site; Genital Diseases, Male; Genital Diseases; Urogenital Diseases; Prostatic Diseases; Male Urogenital Diseases

Study Officials

• Yüksel Ürün

  Ankara University

  STUDY DIRECTOR

Central Study Contacts

Yüksel Ürün

CONTACT

800-555-5555; yukselurun@gmail.com

Satı Coşkun Yazgan

CONTACT

800-555-5555; coskunyazgann491@gmail.com

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: CROSS SECTIONAL
• Target Duration: 1 Day
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Professor doctor

Study Record Dates

• First Submitted: July 24, 2025
• First Posted: July 31, 2025
• Study Start: August 1, 2025
• Primary Completion: December 1, 2025
• Study Completion: December 1, 2025
• Last Updated: July 31, 2025

Record last verified: 2025-07

Data Sharing

• IPD Sharing: Will not share

Locations

TU (1)